FDA Says It Needs More Research Before Deciding to Approve Nasal Spray to Treat Dangerous Allergies
The move comes four months after an FDA advisory committee recommended approval of the device, dubbed neffy. read more >
The move comes four months after an FDA advisory committee recommended approval of the device, dubbed neffy. read more >
Scientists say while these drugs may mark a new era in Alzheimer's therapy, huge questions remain about which patients should try them and how much benefit they'll really notice. read more >
The Food and Drug Administration cleared once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter. read more >
Japanese drugmaker Eisai received conditional approval from the FDA in January based on early results suggesting Leqembi worked by clearing a sticky brain plaque linked to the disease. read more >
The FDA OK'd the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition. read more >
Today's vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by mutated versions as the virus rapidly evolves. read more >
Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers. read more >
The panel of FDA advisers voted unanimously in favor of drugmaker Perrigo's request to sell its once-a-day medication on store shelves alongside eye drops and allergy pills. read more >
It's the first drug for an inherited form of ALS, or amyotrophic lateral sclerosis, a deadly disease that destroys nerve cells needed for basic functions like walking, talking and swallowing. read more >
The justices granted emergency requests from the Biden administration and New York-based Danco Laboratories, maker of the drug mifepristone. They are appealing a lower court ruling that would roll back Food and Drug Administration approval of mifepristone. read more >
The court finds itself immersed in a new fight involving abortion less than a year after conservative justices reversed Roe v. Wade and allowed more than a dozen states to effectively ban abortion outright. read more >
The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. read more >
Global Pharma Healthcare's eyedrops have been linked to 68 bacterial infections in the U.S., including three deaths and eight cases of vision loss. read more >
One in five Medicare recipients currently uses medical marijuana. read more >
The FDA will ask its panel of outside vaccine experts to weigh in at a meeting Thursday. read more >
Before over-the-counter, you usually needed to get your hearing tested and buy hearing aids from a specialist. That's no longer the case. read more >
The trial is important because it shows a drug that attacks a sticky protein called amyloid -- considered one of several culprits behind Alzheimer's -- can delay disease progression. read more >
Health regulators insist Covis Pharma's product doesn't work. read more >
